FDA's Crackdown on Kratom: Salmonella Scare and Supplement Safety
This action is based on the imminent health risk posed by the contamination of this product with Salmonella and the refusal of this company to voluntarily act.
Imagine finding out that your go-to supplement for pain relief or opioid withdrawal could be contaminated with Salmonella. That's exactly what happened when the FDA issued its first-ever mandatory recall of Kratom supplements. In this episode of the 'Recovery From Addiction Podcast', Jennifer Kurtz dives into the implications of this recall and what it means for Kratom users.
She explains that the FDA took this unprecedented step because a company named Triangle Pharmanaturals LLC refused to recall their contaminated products voluntarily. While some companies pulled their products from shelves, Triangle Pharmanaturals stood firm, putting consumers at risk. The podcast also touches on the broader issue of dietary supplement regulation. Unlike prescription drugs, supplements like Kratom aren't subject to pre-market safety testing. This leaves a lot of room for potential hazards, as highlighted by Chuck Bell from Consumers Union.
Jennifer brings in perspectives from various stakeholders, including military veteran Andrew Turner, who has relied on Kratom to manage pain and PTSD. For him, Kratom has been a game-changer, but he now faces uncertainty due to the potential for stricter regulations. This episode is a must-listen if you're curious about the safety of dietary supplements and the ongoing debate around Kratom. Jennifer's discussion sheds light on the need for more stringent oversight to protect consumers from harmful contaminants.